Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market - Global Industry Analysis and Opportunity Assessment, 2020-2030

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market - Global Industry Analysis and Opportunity Assessment, 2020-2030

  • Future Market Insights
  • June 2020
  • Healthcare
  • 345 pages

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Market Background
4.1. COVID19 Crisis Analysis
4.1.1. Current COVID19 Statistics and Probable Future Impact
4.1.2. Current GDP Projection and Probable Impact
4.1.3. Current Economic Projection as compared to 2008 Economic analysis
4.1.4. COVID19 and Impact Analysis
4.1.4.1. Revenue By Drug Class
4.1.4.2. Revenue By Route of Administration
4.1.4.3. Revenue By Country
4.1.5. 2020 Market Scenario
4.1.6. Quarter by Quarter Forecast
4.1.7. Projected recovery Quarter
4.1.8. Recovery Scenario – Short term, Midterm and Long Term Impact
4.2. Macro-Economic Factors
4.2.1. Global GDP Growth Outlook
4.2.2. Global Healthcare Outlook
4.3. Forecast Factors - Relevance & Impact
4.3.1. Historical Growth of Top Players
4.3.2. New Product Approval and Launch
4.3.3. Adoption of MRSA Treatment
4.3.4. Cost of MRSA Treatment
4.3.5. Increasing Epidemic of MRSA Infections
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities

5. Market Context
5.1. Product USPs/ Features
5.2. Epidemiological Forecast for MRSA (2014–2024)
5.2.1.  Hospitalized Incident Cases of MRSA
5.2.2.  Sex-Specific Hospitalized Incident Cases of MRSA
5.2.3.  Age-Specific Hospitalized Incidence of MRSA
5.2.4. Age-Standardized Hospitalized Incidence Rate of MRSA
5.3. Pipeline Assessment
5.3.1. Pipeline Overview
5.3.2. Pipeline Breakdown by Region/Country
5.3.3. Pipeline Breakdown by Molecule Type and Target
5.3.4. Drug Review Designations
5.3.5. Products in Clinical Development
5.4. New Product Approvals
5.5. Clinical Trial Assessment
5.5.1. Clinical Trials Overview
5.5.2. Top Sponsors of Clinical Trials in MRSA
5.5.3. Trial Breakdown by Region
5.5.4. Therapy Area Perspective
5.5.5. Enrolment Analytics
5.6. Product  Adoption / Route of Administration Analysis
5.7. Regulatory Scenario

6. Global MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020-2030

7. Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Class
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015–2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2020-2030
7.3.1. Glycopeptides
7.3.1.1.1. Vancomycin
7.3.2. Lipopeptides
7.3.2.1.1. Daptomycin
7.3.3. Oxazolidinones
7.3.3.1.1. Linezolid
7.3.4. Glycylcycline
7.3.4.1.1. Tigecycline
7.3.5. Streptogramins
7.3.5.1.1. Quinupristin
7.3.5.1.2. Dalfopristin
7.3.6. Lincomycin
7.3.6.1.1. Clindamycin
7.3.7. Tetracycline
7.3.7.1.1. Doxycycline
7.3.7.1.2. Minocycline
7.3.8. Lipoglycopeptides
7.3.8.1.1. Dalbavancin
7.3.8.1.2. Telavancin
7.3.8.1.3. Oritavancin
7.3.9. Antiseptics
7.3.9.1.1. Chlorhexidine
7.3.9.1.2. Cetylpyridinium Chloride
7.3.9.1.3. Hydrogen Peroxide
7.3.9.1.4. Phenols
7.3.10. Naturals/Herbals
7.3.11. Others
7.4. Market Attractiveness Analysis By Drug Class

8. Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
8.3.1. Skin and Soft Tissue Infections (SSTIs)
8.3.2. Pneumonia
8.3.3. Bloodstream Infections
8.3.4. Surgical and Medical Infections
8.3.5. Others
8.4. Market Attractiveness Analysis By Indication

9. Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2020-2030
9.3.1. Intravenous
9.3.2. Oral
9.3.3. Topical
9.3.4. Nasal
9.3.5. Cutaneous
9.3.6. Intramuscular

10. Market Attractiveness Analysis By Route of Administration Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Types of MRSA
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Types of MRSA, 2020-2030
10.3.1. Healthcare Acquired MRSA
10.3.2. Community Acquired MRSA
10.3.3. Hospital Acquired MRSA
10.4. Market Attractiveness Analysis By Types of MRSA

11. Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channels
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channels, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channels, 2020-2030
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. Online Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channels

12. Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia Pacific
12.3.6. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1.  By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Drug Class
13.3.3. By Indication
13.3.4. By Route of Administration
13.3.5. By Types of MRSA
13.3.6. By Distribution Channels
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Latin America MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Drug Class
14.3.3. By Indication
14.3.4. By Route of Administration
14.3.5. By Types of MRSA
14.3.6. By Distribution Channels
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. Europe MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Drug Class
15.3.3. By Indication
15.3.4. By Route of Administration
15.3.5. By Types of MRSA
15.3.6. By Distribution Channels
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. South Asia and Oceania MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. India
16.3.1.2. ASEAN
16.3.1.3. Australia
16.3.1.4. New Zealand
16.3.2. By Drug Class
16.3.3. By Indication
16.3.4. By Route of Administration
16.3.5. By Types of MRSA
16.3.6. By Distribution Channels
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. East Asia MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Drug Class
17.3.3. By Indication
17.3.4. By Route of Administration
17.3.5. By Types of MRSA
17.3.6. By Distribution Channels
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
18.3.1.  By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Drug Class
18.3.3. By Indication
18.3.4. By Route of Administration
18.3.5. By Types of MRSA
18.3.6. By Distribution Channels
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis

19. Emerging Countries MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China MRSA Treatment Market Analysis
19.2.1. By Drug Class
19.2.2. By Indication
19.2.3. By Route of Administration
19.2.4. By Types of MRSA
19.2.5. By Distribution Channels
19.3. India MRSA Treatment Market Analysis
19.3.1. By Drug Class
19.3.2. By Indication
19.3.3. By Route of Administration
19.3.4. By Types of MRSA
19.3.5. By Distribution Channels
19.4. Brazil MRSA Treatment Market Analysis
19.4.1. By Drug Class
19.4.2. By Indication
19.4.3. By Route of Administration
19.4.4. By Types of MRSA
19.4.5. By Distribution Channels

20. Key Countries MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030
20.1. U.S. MRSA Treatment Market Analysis
20.1.1. By Drug Class
20.1.2. By Indication
20.1.3. By Route of Administration
20.1.4. By Types of MRSA
20.1.5. By Distribution Channels
20.2. Canada MRSA Treatment Market Analysis
20.2.1. By Drug Class
20.2.2. By Indication
20.2.3. By Route of Administration
20.2.4. By Types of MRSA
20.2.5. By Distribution Channels
20.3. Mexico MRSA Treatment Market Analysis
20.3.1. By Drug Class
20.3.2. By Indication
20.3.3. By Route of Administration
20.3.4. By Types of MRSA
20.3.5. By Distribution Channels
20.4. U.K. MRSA Treatment Market Analysis
20.4.1. By Drug Class
20.4.2. By Indication
20.4.3. By Route of Administration
20.4.4. By Types of MRSA
20.4.5. By Distribution Channels
20.5. Germany MRSA Treatment Market Analysis
20.5.1. By Drug Class
20.5.2. By Indication
20.5.3. By Route of Administration
20.5.4. By Types of MRSA
20.5.5. By Distribution Channels
20.6. France MRSA Treatment Market Analysis
20.6.1. By Drug Class
20.6.2. By Indication
20.6.3. By Route of Administration
20.6.4. By Types of MRSA
20.6.5. By Distribution Channels
20.7. Italy MRSA Treatment Market Analysis
20.7.1. By Drug Class
20.7.2. By Indication
20.7.3. By Route of Administration
20.7.4. By Types of MRSA
20.7.5. By Distribution Channels
20.8. Spain MRSA Treatment Market Analysis
20.8.1. By Drug Class
20.8.2. By Indication
20.8.3. By Route of Administration
20.8.4. By Types of MRSA
20.8.5. By Distribution Channels
20.9. BENELUX MRSA Treatment Market Analysis
20.9.1. By Drug Class
20.9.2. By Indication
20.9.3. By Route of Administration
20.9.4. By Types of MRSA
20.9.5. By Distribution Channels
20.10. Russia MRSA Treatment Market Analysis
20.10.1. By Drug Class
20.10.2. By Indication
20.10.3. By Route of Administration
20.10.4. By Types of MRSA
20.10.5. By Distribution Channels
20.11. Japan MRSA Treatment Market Analysis
20.11.1. By Drug Class
20.11.2. By Indication
20.11.3. By Route of Administration
20.11.4. By Types of MRSA
20.11.5. By Distribution Channels
20.12. South Korea MRSA Treatment Market Analysis
20.12.1. By Drug Class
20.12.2. By Indication
20.12.3. By Route of Administration
20.12.4. By Types of MRSA
20.12.5. By Distribution Channels
20.13. ASEAN MRSA Treatment Market Analysis
20.13.1. By Drug Class
20.13.2. By Indication
20.13.3. By Route of Administration
20.13.4. By Types of MRSA
20.13.5. By Distribution Channels
20.14. Australia MRSA Treatment Market Analysis
20.14.1. By Drug Class
20.14.2. By Indication
20.14.3. By Route of Administration
20.14.4. By Types of MRSA
20.14.5. By Distribution Channels
20.15. New Zealand MRSA Treatment Market Analysis
20.15.1. By Drug Class
20.15.2. By Indication
20.15.3. By Route of Administration
20.15.4. By Types of MRSA
20.15.5. By Distribution Channels
20.16. GCC Countries MRSA Treatment Market Analysis
20.16.1. By Drug Class
20.16.2. By Indication
20.16.3. By Route of Administration
20.16.4. By Types of MRSA
20.16.5. By Distribution Channels
20.17. Turkey MRSA Treatment Market Analysis
20.17.1. By Drug Class
20.17.2. By Indication
20.17.3. By Route of Administration
20.17.4. By Types of MRSA
20.17.5. By Distribution Channels
20.18. South Africa MRSA Treatment Market Analysis
20.18.1. By Drug Class
20.18.2. By Indication
20.18.3. By Route of Administration
20.18.4. By Types of MRSA
20.18.5. By Distribution Channels

21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional Footprint by Players
21.3.2. Product Foot print by Players
21.3.3. Channel Foot Print by Players

22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive (Tentative List)
22.3.1. Pfizer, Inc.   
22.3.1.1. Overview
22.3.1.2. Product  Portfolio
22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Allergan Plc.
22.3.2.1. Overview
22.3.2.2. Product  Portfolio
22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Johnsons & Johnson
22.3.3.1. Overview
22.3.3.2. Product  Portfolio
22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. Colgate-Palmolive Company
22.3.4.1. Overview
22.3.4.2. Product  Portfolio
22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. The Procter & Gamble
22.3.5.1. Overview
22.3.5.2. Product  Portfolio
22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Merck & Co., Inc.
22.3.6.1. Overview
22.3.6.2. Product  Portfolio
22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Baxter Healthcare Corporation
22.3.7.1. Overview
22.3.7.2. Product  Portfolio
22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. Fresenius Kabi LLC
22.3.8.1. Overview
22.3.8.2. Product  Portfolio
22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Sandoz Inc.
22.3.9.1. Overview
22.3.9.2. Product  Portfolio
22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Teva Pharmaceutical Industries ltd.
22.3.10.1. Overview
22.3.10.2. Product  Portfolio
22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. Mylan N. V.
22.3.11.1. Overview
22.3.11.2. Product  Portfolio
22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
22.3.12. Dr.Reddy's Laboratories Inc.,
22.3.12.1. Overview
22.3.12.2. Product  Portfolio
22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Product Strategy
22.3.12.5.3. Channel Strategy
22.3.13. Cumberland Pharmaceuticals Inc.
22.3.13.1. Overview
22.3.13.2. Product  Portfolio
22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.5.1. Marketing Strategy
22.3.13.5.2. Product Strategy
22.3.13.5.3. Channel Strategy
22.3.14. Durata Therapeutics Inc.
22.3.14.1. Overview
22.3.14.2. Product  Portfolio
22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
22.3.14.4. Sales Footprint
22.3.14.5. Strategy Overview
22.3.14.5.1. Marketing Strategy
22.3.14.5.2. Product Strategy
22.3.14.5.3. Channel Strategy
22.3.15. Melinta Therapeutics, Inc.
22.3.15.1. Overview
22.3.15.2. Product  Portfolio
22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
22.3.15.4. Sales Footprint
22.3.15.5. Strategy Overview
22.3.15.5.1. Marketing Strategy
22.3.15.5.2. Product Strategy
22.3.15.5.3. Channel Strategy
22.3.16. Debiopharm International S.A.
22.3.16.1. Overview
22.3.16.2. Product  Portfolio
22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
22.3.16.4. Sales Footprint
22.3.16.5. Strategy Overview
22.3.16.5.1. Marketing Strategy
22.3.16.5.2. Product Strategy
22.3.16.5.3. Channel Strategy
22.3.17. Akron Pharma Inc.
22.3.17.1. Overview
22.3.17.2. Product  Portfolio
22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
22.3.17.4. Sales Footprint
22.3.17.5. Strategy Overview
22.3.17.5.1. Marketing Strategy
22.3.17.5.2. Product Strategy
22.3.17.5.3. Channel Strategy
22.3.18. Mayne Pharma Group Limited.
22.3.18.1. Overview
22.3.18.2. Product  Portfolio
22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
22.3.18.4. Sales Footprint
22.3.18.5. Strategy Overview
22.3.18.5.1. Marketing Strategy
22.3.18.5.2. Product Strategy
22.3.18.5.3. Channel Strategy
22.3.19. Sun Pharmaceutical Industries Ltd.
22.3.19.1. Overview
22.3.19.2. Product  Portfolio
22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
22.3.19.4. Sales Footprint
22.3.19.5. Strategy Overview
22.3.19.5.1. Marketing Strategy
22.3.19.5.2. Product Strategy
22.3.19.5.3. Channel Strategy
22.3.20. Amneal Pharmaceuticals, Inc.
22.3.20.1. Overview
22.3.20.2. Product  Portfolio
22.3.20.3. Profitability by Market Segments (Product/Channel/Region)
22.3.20.4. Sales Footprint
22.3.20.5. Strategy Overview
22.3.20.5.1. Marketing Strategy
22.3.20.5.2. Product Strategy
22.3.20.5.3. Channel Strategy
22.3.21. Cardinal Health
22.3.21.1. Overview
22.3.21.2. Product  Portfolio
22.3.21.3. Profitability by Market Segments (Product/Channel/Region)
22.3.21.4. Sales Footprint
22.3.21.5. Strategy Overview
22.3.21.5.1. Marketing Strategy
22.3.21.5.2. Product Strategy
22.3.21.5.3. Channel Strategy
22.3.22. Herbal Intervention, LLC
22.3.22.1. Overview
22.3.22.2. Product  Portfolio
22.3.22.3. Profitability by Market Segments (Product/Channel/Region)
22.3.22.4. Sales Footprint
22.3.22.5. Strategy Overview
22.3.22.5.1. Marketing Strategy
22.3.22.5.2. Product Strategy
22.3.22.5.3. Channel Strategy
22.3.23. 3M ESPE Dental Products
22.3.23.1. Overview
22.3.23.2. Product  Portfolio
22.3.23.3. Profitability by Market Segments (Product/Channel/Region)
22.3.23.4. Sales Footprint
22.3.23.5. Strategy Overview
22.3.23.5.1. Marketing Strategy
22.3.23.5.2. Product Strategy
22.3.23.5.3. Channel Strategy
22.3.24. Patterson Dental Supply Inc.
22.3.24.1. Overview
22.3.24.2. Product  Portfolio
22.3.24.3. Profitability by Market Segments (Product/Channel/Region)
22.3.24.4. Sales Footprint
22.3.24.5. Strategy Overview
22.3.24.5.1. Marketing Strategy
22.3.24.5.2. Product Strategy
22.3.24.5.3. Channel Strategy
22.3.25. The Kroger Company
22.3.25.1. Overview
22.3.25.2. Product  Portfolio
22.3.25.3. Profitability by Market Segments (Product/Channel/Region)
22.3.25.4. Sales Footprint
22.3.25.5. Strategy Overview
22.3.25.5.1. Marketing Strategy
22.3.25.5.2. Product Strategy
22.3.25.5.3. Channel Strategy
22.3.26. Crown Laboratories, Inc.
22.3.26.1. Overview
22.3.26.2. Product  Portfolio
22.3.26.3. Profitability by Market Segments (Product/Channel/Region)
22.3.26.4. Sales Footprint
22.3.26.5. Strategy Overview
22.3.26.5.1. Marketing Strategy
22.3.26.5.2. Product Strategy
22.3.26.5.3. Channel Strategy
22.3.27. Atlantic Biologicals Corp.
22.3.27.1. Overview
22.3.27.2. Product  Portfolio
22.3.27.3. Profitability by Market Segments (Product/Channel/Region)
22.3.27.4. Sales Footprint
22.3.27.5. Strategy Overview
22.3.27.5.1. Marketing Strategy
22.3.27.5.2. Product Strategy
22.3.27.5.3. Channel Strategy
22.3.28. Bio-Germ Protection LLC
22.3.28.1. Overview
22.3.28.2. Product  Portfolio
22.3.28.3. Profitability by Market Segments (Product/Channel/Region)
22.3.28.4. Sales Footprint
22.3.28.5. Strategy Overview
22.3.28.5.1. Marketing Strategy
22.3.28.5.2. Product Strategy
22.3.28.5.3. Channel Strategy
22.3.29. Apollo Health and Beauty Care
22.3.29.1. Overview
22.3.29.2. Product  Portfolio
22.3.29.3. Profitability by Market Segments (Product/Channel/Region)
22.3.29.4. Sales Footprint
22.3.29.5. Strategy Overview
22.3.29.5.1. Marketing Strategy
22.3.29.5.2. Product Strategy
22.3.29.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

 

Table 01: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 02: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 03: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 04: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 05: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 06: Global MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 07: North America MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 08: North America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 09: North America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 10: North America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 11: North America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 12: North America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 13: Latin America MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 14: Latin America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 15: Latin America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 16: Latin America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 17: Latin America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 18: Latin America MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 19: Europe MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 20: Europe MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 21: Europe MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 22: Europe MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 23: Europe MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 24: Europe MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 25: South Asia MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 26: South Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 27: South Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 28: South Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 29: South Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 30: South Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 31: East Asia MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 32: East Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 33: East Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 34: East Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 35: East Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 36: East Asia MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 37: Oceania MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 38: Oceania MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 39: Oceania MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 40: Oceania MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 41: Oceania MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 42: Oceania MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 43: MEA MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 44: MEA MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 45: MEA MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 46: MEA MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 47: MEA MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 48: MEA MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 49: China MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 50: China MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 51: China MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 52: China MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 53: China MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 54: India MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 55: India MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 56: India MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 57: India MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 58: India MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 59: Brazil MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 60: Brazil MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 61: Brazil MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Route of Administration
Table 62: Brazil MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Types of MRSA
Table 63: Brazil MRSA Infections Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

 

Figure 01: Global MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 02: Global MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 03: Global MRSA Treatment Market Absolute $ Opportunity, 2020 - 2030
Figure 04: Global MRSA Infections Treatment Market Share Analysis (%), By Drug Class, 2020-2030
Figure 05: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Drug Class, 2020-2030
Figure 06: Global MRSA Infections Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 07: Global MRSA Infections Treatment Market Share Analysis (%), By Indication, 2020-2030
Figure 08: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Indication, 2020-2030
Figure 09: Global MRSA Infections Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 10: Global MRSA Infections Treatment Market Share Analysis (%), By Route of Administration, 2020-2030
Figure 11: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Route of Administration, 2020-2030
Figure 12: Global MRSA Infections Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 13: Global MRSA Infections Treatment Market Share Analysis (%), By Types of MRSA, 2020-2030
Figure 14: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Types of MRSA, 2020-2030
Figure 15: Global MRSA Infections Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 16: Global MRSA Infections Treatment Market Share Analysis (%), By Distribution Channel, 2020-2030
Figure 17: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2020-2030
Figure 18: Global MRSA Infections Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 19: Global MRSA Infections Treatment Market Share Analysis (%), By Region, 2020-2030
Figure 20: Global MRSA Infections Treatment Market Y-o-Y Analysis (%), By Region, 2020-2030
Figure 21: Global MRSA Infections Treatment Market Attractiveness Analysis by Region, 2020-2030
Figure 22: North America MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 23: North America MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 24: North America MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 25: North America MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 26: North America MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)
Figure 27: North America MRSA Treatment Market Value Share, By Country, 2020 (E)
Figure 28: North America MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 29: North America MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 30: North America MRSA Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 31: North America MRSA Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 32: North America MRSA Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 33: North America MRSA Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 34: North America MRSA Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 35: North America MRSA Treatment Market Attractiveness Analysis by Country, 2020-2030
Figure 36: Latin America MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 37: Latin America MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 38: Latin America MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 39: Latin America MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 40: Latin America MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)
Figure 41: Latin America MRSA Treatment Market Value Share, By Country, 2020 (E)
Figure 42: Latin America MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 43: Latin America MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 44: Latin America MRSA Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 45: Latin America MRSA Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 46: Latin America MRSA Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 47: Latin America MRSA Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 48: Latin America MRSA Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 49: Latin America MRSA Treatment Market Attractiveness Analysis by Country, 2020-2030
Figure 50: Europe MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 51: Europe MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 52: Europe MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 53: Europe MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 54: Europe MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)
Figure 55: Europe MRSA Treatment Market Value Share, By Country, 2020 (E)
Figure 56: Europe MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 57: Europe MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 58: Europe MRSA Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 59: Europe MRSA Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 60: Europe MRSA Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 61: Europe MRSA Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 62: Europe MRSA Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 63: Europe MRSA Treatment Market Attractiveness Analysis by Country, 2020-2030
Figure 64: South Asia MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 65: South Asia MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 66: South Asia MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 67: South Asia MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 68: South Asia MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)
Figure 69: South Asia MRSA Treatment Market Value Share, By Country, 2020 (E)
Figure 70: South Asia MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 71: South Asia MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 72: South Asia MRSA Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 73: South Asia MRSA Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 74: South Asia MRSA Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 75: South Asia MRSA Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 76: South Asia MRSA Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 77: South Asia MRSA Treatment Market Attractiveness Analysis by Country, 2020-2030
Figure 78: East Asia MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 79: East Asia MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 80: East Asia MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 81: East Asia MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 82: East Asia MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)
Figure 83: East Asia MRSA Treatment Market Value Share, By Country, 2020 (E)
Figure 84: East Asia MRSA Treatment Market Value Analysis (US$ Mn), 2015-2019
Figure 85: East Asia MRSA Treatment Market Value Forecast (US$ Mn), 2020-2030
Figure 86: East Asia MRSA Treatment Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 87: East Asia MRSA Treatment Market Attractiveness Analysis by Route of Administration, 2020-2030
Figure 88: East Asia MRSA Treatment Market Attractiveness Analysis by Indication, 2020-2030
Figure 89: East Asia MRSA Treatment Market Attractiveness Analysis by Types of MRSA, 2020-2030
Figure 90: East Asia MRSA Treatment Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 91: East Asia MRSA Treatment Market Attractiveness Analysis by Country, 2020-2030
Figure 92: Oceania MRSA Treatment Market Value Share, By Drug Class, 2020 (E)
Figure 93: Oceania MRSA Treatment Market Value Share, By Route of Administration, 2020 (E)
Figure 94: Oceania MRSA Treatment Market Value Share, By Indications, 2020 (E)
Figure 95: Oceania MRSA Treatment Market Value Share, By Types of MRSA, 2020 (E)
Figure 96: Oceania MRSA Treatment Market Value Share, By Distribution Channel, 2020 (E)

 

Have query on this report?

Success Stories

Our Clients